Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates

Current Opinion in HIV and AIDS

Volumn 8, Issue 4, 2013, Pages 273-279

  Schmitz, Joern E ^a   Korioth Schmitz, Birgit ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

immunopathogenesis; nonhuman primates; simian immunodeficiency virus

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG EFFICACY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOPATHOGENESIS; INFECTION PREVENTION; INNATE IMMUNITY; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN VIRUS; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84880332697     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328361cf5b     Document Type: Review

References (105)

1. Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol Med 2012; 18:182-192.
2. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 2011; 1:a006841.
3. Saunders KO, Rudicell RS, Nabel GJ. The design and evaluation of HIV-1 vaccines. AIDS 2012; 26:1293-1302.
4. Letvin NL, Hunt RD, Finberg R. Animal models of AIDS. Semin Oncol 1984; 11:18-28.
5. Desrosiers RC, Letvin NL. Animal models for acquired immunodeficiency syndrome. Rev Infect Dis 1987; 9:438-446.
6. Hatziioannou T, Evans DT. Animal models for HIV/AIDS research. Nat Rev Microbiol 2012; 10:852-867.
7. Shaw GM, Hunter E. HIV transmission. Cold Spring Harb Perspect Med 2012, Nov 1;2(11). pii: a006965. doi: 10.1101/cshperspect.a006965.
8. Stone M, Keele BF, Ma ZM, et al. A limited number of simian immunodeficiency virus (SIV) env variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J Virol 2010; 84:7083-7095.
9. Strickland SL, Gray RR, Lamers SL, et al. Significant genetic heterogeneity of the SIVmac251 viral swarm derived from different sources. AIDS Res Hum Retroviruses 2011; 27:1327-1332.
10. Del Prete GQ, Scarlotta M, Newman L, et al. Comparative characterization of transfection-and infection-derived SIV challenge stocks for in vivo non-human primate studies. J Virol 2013; 87:4584-4595.
11. Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011; 62:127-139.
12. Maingat F, Halloran B, Acharjee S, et al. Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress. FASEB J 2011; 25:2211-2220.
13. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogen-esis of HIV infection and AIDS. Clin Microbiol Rev 2013; 26:2-18.
14. Giavedoni LD, Chen HL, Hodara VL, et al. Impact of mucosal inflammation on oral simian immunodeficiency virus transmission. J Virol 2013; 87:1750-1758.
15. Klatt NR, Canary LA, Sun X, et al. Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. J Clin Invest 2013; 123:903-907.
16. Kwa S, Kannanganat S, Nigam P, et al. Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques. Blood 2011; 118:2763-2773.
17. Ansari AA, Reimann KA, Mayne AE, et al. Blocking of alpha4beta7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol 2011; 186:1044-1059.
18. Sandler NG, Douek DC. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 2012; 10:655-666.
19. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
20. Handley SA, Thackray LB, Zhao G, et al. Pathogenic simian immuno-deficiency virus infection is associated with expansion of the enteric virome. Cell 2012; 151:253-266.
21. Alammar L, Gama L, Clements JE. Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol 2011; 186:4008-4018.
22. Kelly KM, Tarwater PM, Karper JM, et al. Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques. AIDS 2012; 26:815-823.
23. Renner NA, Sansing HA, Morici LA, et al. Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion. J Neurovirol 2012; 18:213-221.
24. Laast VA, Shim B, Johanek LM, et al. Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am J Pathol 2011; 179:2337-2345.
25. Williams K, Burdo TH. Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans. J Neuroimmune Pharmacol 2012; 7:363-371.
26. Moore AC, Bixler SL, Lewis MG, et al. Mucosal and peripheral Lin-HLA-DR\+ CD11c/123-CD13\+ CD14-mononuclear cells are preferentially infected during acute simian immunodeficiency virus infection. J Virol 2012; 86:1069-1078.
27. Laforge M, Campillo-Gimenez L, Monceaux V, et al. HIV/SIV infection primes monocytes and dendritic cells for apoptosis. PLoS Pathog 2011; 7:e1002087.
28. Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004; 5:1109-1115.
29. Nomaguchi M, Fujita M, Adachi A. The fourth major restriction factor against HIV/SIV. Front Microbiol 2011; 2:132.
30. Schaller T, Goujon C, Malim MH. AIDS/HIV. HIV interplay with SAMHD1. Science 2012; 335:1313-1314.
31. Letvin NL, Rao SS, Montefiori DC, et al. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci Transl Med 2011; 3:81ra36.
32. Fenizia C, Keele BF, Nichols D, et al. TRIM5alpha does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvacci-nated Indian rhesus macaques following intrarectal challenge exposure. J Virol 2011; 85:12399-12409.
33. Mussil B, Sauermann U, Motzkus D, et al. Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys. Retro-virology 2011; 8:77.
34. Laguette N, Benkirane M. How SAMHD1 changes our view of viral restriction. Trends Immunol 2012; 33:26-33.
35. St Gelais C, Wu L. SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 2011; 8:55.
36. Brandariz-Nunez A, Valle-Casuso JC, White TE, et al. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology 2012; 9:49.
37. Choi EI, Reimann KA, Letvin NL. In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J Virol 2008; 82:6758-6761.
38. Reeves RK, Gillis J, Wong FE, et al. CD16-natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010; 115:4439-4446.
39. Hellmann I, Letvin NL, Schmitz JE. KIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NKcell subsets in SIV-infected Mamu-A*01-rhesus macaques. J Virol 2013; 87:5305-5310.
40. Hellmann I, Schmitz JE, Letvin NL. Activating KIR copy number variation is associated with granzyme B release by NK cells during primary simian immunodeficiency virus infection in rhesus monkeys. J Virol 2012; 86:13103-13107.
41. Hellmann I, LimSY, Gelman RS, Letvin NL. Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys. PLoS Pathog 2011; 7:e1002436.
42. Sun Y, Asmal M, LaneS, et al. Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys. J Virol 2011; 85:6906-6912.
43. Alpert MD, Heyer LN, Williams DE, et al. A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1-or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays. J Virol 2012; 86:12039-12052.
44. PollaraJ, Hart L, Brewer F, et al. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 2011; 79:603-612.
45. Asmal M, Sun Y, Lane S, et al. Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses. J Virol 2011; 85:5465-5475.
46. HeX, Li D, LuoZ, et al. Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection. PLoS One 2013; 8:e56309.
47. Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83:3719-3733.
48. Katsikis PD, Mueller YM, Villinger F. The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? PLoS Pathog 2011; 7:e1002055.
49. Lugli E, Mueller YM, Lewis MG, et al. IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques. Blood 2011; 118:2520-2529.
50. Vassena L, Miao H, Cimbro R, et al. Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog 2012; 8:e1002636.
51. Picker LJ, Reed-Inderbitzin EF, Hagen SI, et al. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J Clin Invest 2006; 116:1514-1524.
52. Peretz Y, Cameron C, Sekaly RP. Dissecting the HIV-specific immune response: a systems biology approach. Curr Opin HIV AIDS 2012; 7:17-23.
53. Benecke A, Gale M, Katze MG. Dynamics of innate immunity are key to chronic immune activation in AIDS. Curr Opin HIV AIDS 2012; 7:79-85.
54. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-860.
55. Nigam P, Velu V, Kannanganat S, et al. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 2010; 184:1690-1701.
56. George J, Cofano EB, Lybarger E, et al. Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques. AIDS Res Hum Retroviruses 2011; 27:763-775.
57. Xu H, Wang X, Lackner AA, Veazey RS. CD8 down-regulation and functional impairment of SIV-specific cytotoxic T lymphocytes in lymphoid and mucosal tissues during SIV infection. J Leukoc Biol 2013; 93: doi: 10.1189/jlb.1112580.
58. Vanderford TH, Bleckwehl C, Engram JC, et al. Viral CTL escape mutants are generated in lymph nodes and subsequently become fixed in plasma and rectal mucosa during acute SIV infection of macaques. PLoS Pathog 2011; 7:e1002048.
59. Cale EM, Hraber P, Giorgi EE, et al. Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. J Virol 2011; 85:3746-3757.
60. Burwitz BJ, Sacha JB, Reed JS, et al. Pyrosequencing reveals restricted patterns of CD8+ T cell escape-associated compensatory mutations in simian immunodeficiency virus. J Virol 2011; 85:13088-13096.
61. Hughes AL, Becker EA, Lauck M, et al. SIV genome-wide pyrosequencing provides a comprehensive and unbiased view of variation within and outside CD8 T lymphocyte epitopes. PLoS One 2012; 7:e47818.
62. Nomura T, Matano T. Association of MHC-I genotypes with disease progression in HIV/SIV infections. Front Microbiol 2012; 3:234.
63. Budde ML, Greene JM, Chin EN, et al. Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques. J Virol 2012; 86:7596-7604.
64. Moore C, Sidney J, English AM, et al. Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301). Immunogenetics 2012; 64:461-468.
65. Mothe BR, Southwood S, Sidney J, et al. Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles. Immunogenetics 2013; Feb. ISSN1432-1211. doi: 10.1007/s00251-013-0686-9.
66. Nomura T, Yamamoto H, Shiino T, et al. Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in burmese rhesus macaques. J Virol 2012; 86:6481-6490.
67. Hartigan-O'Connor DJ, Abel K, Van Rompay KK, et al. SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci Transl Med 2012; 4:136ra169.
68. Zeng M, Haase AT, Schacker TW. Lymphoid tissue structure and HIV-1 infection: life or death for T cells. Trends Immunol 2012; 33:306-314.
69. Zeng M, Smith AJ, Wietgrefe SW, et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest 2011; 121:998-1008.
70. Breed MW, Jordan AP, Aye PP, et al. Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression. J Virol 2013; 87:1528-1543.
71. Okoye AA, Rohankhedkar M, AbanaC, et al. Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection. J Exp Med 2012; 209:641-651.
72. Okoye A, Meier-Schellersheim M, Brenchley JM, et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007; 204:2171-2185.
73. Petrovas C, Yamamoto T, Gerner MY, et al. CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest 2012; 122:3281-3294.
74. Vinuesa CG. HIV and T follicular helper cells: a dangerous relationship. J Clin Invest 2012; 122:3059-3062.
75. Xu Y, Weatherall C, Bailey M, et al. Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol 2013; 87:3760-3773.
76. Hong JJ, Amancha PK, Rogers K, et al. Spatial alterations between CD4(+) T follicular helper, B, and CD8(+)T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape. J Immunol 2012; 188:3247-3256.
77. Klatt NR, Vinton CL, Lynch RM, et al. SIV infection of rhesus macaques results in dysfunctional T-and B-cell responses to neo and recall Leishmania major vaccination. Blood 2011; 118:5803-5812.
78. Hufert FT, van Lunzen J, Janossy G, et al. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. AIDS 1997; 11:849-857.
79. Plantier JC, Leoz M, Dickerson JE, et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009; 15:871-872.
80. Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 2012; 337:183-186.
81. Huang J, Ofek G, Laub L, et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 2012; 491:406-412.
82. Verkoczy L, Kelsoe G, Moody MA, Haynes BF. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr Opin Immunol 2011; 23:383-390.
83. Klein F, Halper-Stromberg A, Horwitz JA, et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature 2012; 492:118-122.
84. Bar KJ, Tsao CY, Iyer SS, et al. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog 2012; 8:e1002721.
85. Martinez-Navio JM, Desrosiers RC. Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus. J Virol 2012; 86:12484-12493.
86. Chaoul N, Burelout C, Peruchon S, et al. Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus. Retro-virology 2012; 9:43.
87. Yeh WW, Brassard LM, Miller CA, et al. Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys. J Virol 2012; 86:7052-7059.
88. Demberg T, Brocca-Cofano E, Xiao P, et al. Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIV-mac251-infected rhesus macaques. J Virol 2012; 86:12591-12604.
89. Fofana IB, Colantonio AD, Reeves RK, et al. Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes. J Immunol Methods 2011; 370:75-85.
90. Moody MA, Haynes BF. Antigen-specific B cell detection reagents: use and quality control. Cytometry A 2008; 73: 1086-1092.
91. Poignard P, Moldt B, Maloveste K, et al. Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2. PLoS One 2012; 7:e42209.
92. Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013; 56(9). doi: 10.1093/cid/cit048.
93. Barouch DH, Liu J, Li H, et al. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 2012; 482:89-93.
94. Picker LJ, Hansen SG, Lifson JD. New paradigms for HIV/AIDS vaccine development. Annu Rev Med 2012; 63:95-111.
95. Walker LM, Sok D, Nishimura Y, et al. Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5SIV/HIV chimeric virus infected macaque. Proc Natl Acad Sci USA 2011; 108:20125-20129.
96. Pandrea I, Apetrei C. Where the wild things are: pathogenesis of SIV infection in African nonhuman primate hosts. Curr HIV/AIDS Rep 2010; 7:28-36.
97. Ma D, Jasinska A, Kristoff J, et al. SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations. PLoS Pathog 2013; 9:e1003011.
98. Schmitz JE, Ma ZM, Hagan EA, et al. Memory CD4(\+) T lymphocytes in the gastrointestinal tract are a major source of cell-associated simian immunodeficiency virus in chronic nonpathogenic infection of African green monkeys. J Virol 2012; 86:11380-11385.
99. Klatt NR, Villinger F, Bostik P, et al. Availability of activated CD4\+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest 2008; 118:2039-2049.
100. Chahroudi A, Bosinger SE, Vanderford TH, et al. Natural SIV hosts: showing AIDS the door. Science 2012; 335:1188-1193.
101. Mendoza D, Migueles SA, Rood JE, et al. Cytotoxic capacity of SIV-specific CD8(\+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques. PLoS Pathog 2013; 9:e1003195.
102. Zahn RC, Rett MD, Li M, et al. Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. Blood 2010; 115:3070-3078.
103. Queen SE, Mears BM, Kelly KM, et al. Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. J Virol 2011; 85:9167-9175.
104. Donahue DA, Wainberg MA. Cellular and molecular mechanisms involved in the establishment of HIV-1 latency. Retrovirology 2013; 10:11.
105. Autran B, Descours B, Bacchus C. Immune control of HIV-1 reservoirs. Curr Opin HIV AIDS 2013; 8:204-210.